SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 5/01/15 Biolase, Inc 10-Q 3/31/15 69:7.4M ActiveDisclosure/FA |
Document/Exhibit Description Pages Size 1: 10-Q Quarterly Report HTML 423K 2: EX-10.1 Material Contract HTML 67K 3: EX-10.3 Material Contract HTML 55K 4: EX-31.1 Certification -- §302 - SOA'02 HTML 27K 5: EX-31.2 Certification -- §302 - SOA'02 HTML 27K 6: EX-32.1 Certification -- §906 - SOA'02 HTML 21K 7: EX-32.2 Certification -- §906 - SOA'02 HTML 21K 47: R1 Document and Entity Information HTML 42K 37: R2 Consolidated Balance Sheets (Unaudited) HTML 129K 45: R3 Consolidated Balance Sheets (Unaudited) HTML 49K (Parenthetical) 49: R4 Consolidated Statements Of Operations And HTML 102K Comprehensive Loss (Unaudited) 64: R5 Consolidated Statements Of Cash Flows (Unaudited) HTML 141K 39: R6 Description of Business and Basis of Presentation HTML 31K 44: R7 Summary of Significant Accounting Policies HTML 34K 34: R8 Stock-Based Awards and Per Share Information HTML 187K 26: R9 Inventory HTML 41K 65: R10 Property, Plant, and Equipment HTML 60K 51: R11 Intangible Assets and Goodwill HTML 112K 50: R12 Accrued Liabilities and Deferred Revenue HTML 95K 55: R13 Lines Of Credit and Other Borrowings HTML 35K 56: R14 Commitments and Contingencies HTML 48K 54: R15 Segment Information HTML 46K 57: R16 Concentrations HTML 50K 46: R17 Income Taxes HTML 29K 48: R18 Subsequent Event HTML 24K 53: R19 Accounting Policies (Policies) HTML 64K 69: R20 Stock-Based Awards and Per Share Information HTML 190K (Tables) 60: R21 Inventory (Tables) HTML 39K 41: R22 Property, Plant, and Equipment (Tables) HTML 58K 52: R23 Intangible Assets and Goodwill (Tables) HTML 106K 43: R24 Accrued Liabilities and Deferred Revenue (Tables) HTML 98K 20: R25 Segment Information (Tables) HTML 39K 61: R26 Concentrations (Tables) HTML 48K 66: R27 Description of Business and Basis of Presentation HTML 32K - Additional Information (Detail) 30: R28 Summary of Significant Accounting Policies - HTML 24K Additional Information (Detail) 29: R29 Stock-Based Awards and Per Share Information - HTML 142K Additional Information (Detail) 32: R30 Classification of Compensation Expense Associated HTML 37K with Share-Based Payments (Detail) 33: R31 Assumptions Used in Estimating Fair Value of Stock HTML 30K Options Granted (Detail) 35: R32 Summary of Option Activity (Detail) HTML 79K 18: R33 Cash Proceeds Along with Fair Value Disclosures HTML 37K Related to Grants, Exercises, and Vested Options (Detail) 58: R34 Summary of Warrant Activity (Detail) HTML 39K 40: R35 Components of Inventory (Detail) HTML 33K 42: R36 Inventory - Additional Information (Detail) HTML 24K 23: R37 Summary of Property, Plant, and Equipment (Detail) HTML 53K 68: R38 Property, Plant, and Equipment - Additional HTML 26K Information (Detail) 14: R39 Intangible Assets and Goodwill - Additional HTML 26K Information (Detail) 36: R40 Intangible Assets and Related Accumulated HTML 57K Amortization (Detail) 63: R41 Components of Accrued Liabilities (Detail) HTML 51K 22: R42 Changes in Initial Product Warranty Accrual and HTML 39K Expenses Under Initial and Extended Warranties (Detail) 28: R43 Accrued Liabilities and Deferred Revenue - HTML 25K Additional Information (Detail) 31: R44 Summary of Deferred Revenue (Detail) HTML 29K 38: R45 Lines of Credit and Other Borrowings - Additional HTML 87K Information (Detail) 17: R46 Commitments and Contingencies - Additional HTML 111K Information (Detail) 25: R47 Segment Information - Additional Information HTML 41K (Detail) 15: R48 Summary of Net Revenue by Geographic Location HTML 28K (Detail) 62: R49 Concentrations - Summary of Net Revenue from HTML 41K Various Products (Detail) 21: R50 Concentrations - Additional Information (Detail) HTML 33K 59: R51 Income Taxes - Additional Information (Detail) HTML 34K 24: R52 Subsequent Event - Additional Information (Detail) HTML 38K 67: XML IDEA XML File -- Filing Summary XML 101K 16: EXCEL IDEA Workbook of Financial Reports XLSX 116K 27: EXCEL IDEA Workbook of Financial Reports (.xls) XLS 1.10M 8: EX-101.INS XBRL Instance -- biol-20150331 XML 1.39M 10: EX-101.CAL XBRL Calculations -- biol-20150331_cal XML 140K 11: EX-101.DEF XBRL Definitions -- biol-20150331_def XML 333K 12: EX-101.LAB XBRL Labels -- biol-20150331_lab XML 975K 13: EX-101.PRE XBRL Presentations -- biol-20150331_pre XML 695K 9: EX-101.SCH XBRL Schema -- biol-20150331 XSD 147K 19: ZIP XBRL Zipped Folder -- 0001564590-15-003181-xbrl Zip 114K
Exhibit 32.1
CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER
PURSUANT TO 18 U.S.C. § 1350
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of BIOLASE, Inc. (the “Company”) on Form 10-Q for the quarter ended March 31, 2015 (the “Report”), I, Jeffrey M. Nugent, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:
(i) the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, and
(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: May 1, 2015 |
|
|
|
|
President and Chief Executive Officer |
This ‘10-Q’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 5/1/15 | None on these Dates | ||
For Period end: | 3/31/15 | |||
List all Filings |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/31/21 Biolase, Inc. 10-K 12/31/20 88:15M ActiveDisclosure/FA 12/08/20 Biolase, Inc. S-1/A 3:585K Donnelley … Solutions/FA |